Skip to main content
Clinical Trials/ACTRN12620001013954
ACTRN12620001013954
Completed
未知

PRospective Observational Study of perioperative OXygen administration (PROSOX) in patients undergoing major non-cardiac surgery under general anaesthesia in Australia and New Zealand.

The Alfred Hospital0 sites150 target enrollmentOctober 7, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypoxia
Sponsor
The Alfred Hospital
Enrollment
150
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 7, 2020
End Date
December 12, 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
The Alfred Hospital

Eligibility Criteria

Inclusion Criteria

  • The anaesthesia events of participating anaesthetists will be eligible for inclusion if all of the following inclusion criteria are met:
  • 1\.Patient at least 18 years of age, ASA 3 or 4
  • 2\.Non\-cardiac surgery performed under general anaesthesia
  • 3\.Expected surgical duration of at least 120 minutes and an anticipated postoperative in hospital stay of at least one night

Exclusion Criteria

  • The anaesthesia event will be excluded if any of the following exclusion criteria are met:
  • 1\.Patient is pregnant or receiving supplemental oxygen immediately prior to surgery
  • 2\.Site primary investigator view that there exists an indication for or contraindication to specified intraoperative oxygen therapy, which may include but is not limited to severe COPD, previous bleomycin or cisplatin chemotherapy, surgical procedures with a risk of airway fire, and thoracic surgery
  • 3\.A prior anaesthesia event already recruited from the individual anaesthetist providing patient care in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials